Blockbuster weight loss drugs have been arguably the biggest health story of the last several years — and there are no signs ...

Results from a new study showed people taking Wegovy (semaglutide) for weight loss were 33 percent less likely to die of COVID-19 than people taking placebo. They were also 15 percent less likely ...

In July, the U.S. Food and Drug Administration warned that people are overdosing on compounded semaglutide injectable ...

The move to self-administration with a syringe and needle, just like how insulin is often taken for diabetes, means a whole ...

Women who take Wegovy to treat obesity have the greatest likelihood of achieving 10% or more weight loss in a year, according to a Cleveland Clinic study published Friday. Michael Siluk ...

A slow-release form of semaglutide could allow people who use Wegovy or Ozempic to get shots once a month, instead of the ...

With so many kids already taking weight loss injectables like Ozempic, a new finding from the company behind the blockbuster ...

If you buy through links on this page, we may earn a small commission. Here’s our process. Wegovy is a weight loss medication that you can only get with a prescription from a licensed healthcare ...

More Tennessee companies are covering weight-loss injections in health care benefit plans. This could impact the state's high ...

While GLP-1 medications like Ozempic and Wegovy hold promise for both weight loss and diabetes management, their potential for accidental misuse requires caution.

Novo Nordisk, maker of Ozempic and Wegovy, now has a market capitalization of more than ... who are willing to ...

9, 2024 (HealthDay News) -- A slow-release form of semaglutide could allow people who use Wegovy or Ozempic to ... hydrogel doesn’t require a special syringe, researchers said.